Graciosa Q Teixeira1, Zhiyao Yong2, Amelie Kuhn3, Jana Riegger3, Raquel M Goncalves2,4,5,6, Michael Ruf7, Uwe M Mauer8, Markus Huber-Lang9, Anita Ignatius2, Rolf E Brenner6, Cornelia Neidlinger-Wilke2. 1. Institute of Orthopaedic Research and Biomechanics, Trauma Research Centre, Ulm University, Ulm, Germany. graciosa.teixeira@uni-ulm.de. 2. Institute of Orthopaedic Research and Biomechanics, Trauma Research Centre, Ulm University, Ulm, Germany. 3. Division for Biochemistry of Joint and Connective Tissue Diseases, Department of Orthopedics, Ulm University, Ulm, Germany. 4. Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal. 5. Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto, Portugal. 6. Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal. 7. Center for Spine Surgery, Orthopedics, and Traumatology, SRH-Klinikum Karlsbad-Langensteinbach, Karlsbad, Germany. 8. Department of Neurosurgery, German Armed Forces Hospital, Ulm, Germany. 9. Institute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Abstract
PURPOSE: Formation of terminal complement complex (TCC), a downstream complement system activation product inducing inflammatory processes and cell lysis, has been identified in degenerated discs. However, it remains unclear which molecular factors regulate complement activation during disc degeneration (DD). This study investigated a possible involvement of the pro-inflammatory cytokine interleukin-1β (IL-1β) and the lysosomal protease cathepsin D (CTSD). METHODS: Disc biopsies were collected from patients suffering from DD (n = 43) and adolescent idiopathic scoliosis (AIS, n = 13). Standardized tissue punches and isolated cells from nucleus pulposus (NP), annulus fibrosus (AF) and endplate (EP) were stimulated with 5% human serum (HS) alone or in combination with IL-1β, CTSD or zymosan. TCC formation and modulation by the complement regulatory proteins CD46, CD55 and CD59 were analysed. RESULTS: In DD tissue cultures, IL-1β stimulation decreased the percentage of TCC + cells in AF and EP (P < 0.05), whereas CTSD stimulation significantly increased TCC deposition in NP (P < 0.01) and zymosan in EP (P < 0.05). Overall, the expression of CD46, CD55 and CD59 significantly increased in all isolated cells during culture (P < 0.05). Moreover, cellular TCC deposition was HS concentration dependent but unaffected by IL-1β, CTSD or zymosan. CONCLUSION: These results suggest a functional relevance of IL-1β and CTSD in modulating TCC formation in DD, with differences between tissue regions. Although strong TCC deposition may represent a degeneration-associated event, IL-1β may inhibit it. In contrast, TCC formation was shown to be triggered by CTSD, indicating a multifunctional involvement in disc pathophysiology.
PURPOSE: Formation of terminal complement complex (TCC), a downstream complement system activation product inducing inflammatory processes and cell lysis, has been identified in degenerated discs. However, it remains unclear which molecular factors regulate complement activation during disc degeneration (DD). This study investigated a possible involvement of the pro-inflammatory cytokine interleukin-1β (IL-1β) and the lysosomal protease cathepsin D (CTSD). METHODS: Disc biopsies were collected from patients suffering from DD (n = 43) and adolescent idiopathic scoliosis (AIS, n = 13). Standardized tissue punches and isolated cells from nucleus pulposus (NP), annulus fibrosus (AF) and endplate (EP) were stimulated with 5% human serum (HS) alone or in combination with IL-1β, CTSD or zymosan. TCC formation and modulation by the complement regulatory proteins CD46, CD55 and CD59 were analysed. RESULTS: In DD tissue cultures, IL-1β stimulation decreased the percentage of TCC + cells in AF and EP (P < 0.05), whereas CTSD stimulation significantly increased TCC deposition in NP (P < 0.01) and zymosan in EP (P < 0.05). Overall, the expression of CD46, CD55 and CD59 significantly increased in all isolated cells during culture (P < 0.05). Moreover, cellular TCC deposition was HS concentration dependent but unaffected by IL-1β, CTSD or zymosan. CONCLUSION: These results suggest a functional relevance of IL-1β and CTSD in modulating TCC formation in DD, with differences between tissue regions. Although strong TCC deposition may represent a degeneration-associated event, IL-1β may inhibit it. In contrast, TCC formation was shown to be triggered by CTSD, indicating a multifunctional involvement in disc pathophysiology.
Entities:
Keywords:
Back pain; Complement system activation; Inflammation; Innate immunity; Intervertebral disc degeneration
Authors: K Ariga; K Yonenobu; T Nakase; M Kaneko; S Okuda; Y Uchiyama; H Yoshikawa Journal: Spine (Phila Pa 1976) Date: 2001-12-15 Impact factor: 3.468
Authors: Kenneth M C Cheung; Jaro Karppinen; Danny Chan; Daniel W H Ho; You-Qiang Song; Pak Sham; Kathryn S E Cheah; John C Y Leong; Keith D K Luk Journal: Spine (Phila Pa 1976) Date: 2009-04-20 Impact factor: 3.468
Authors: V C Duance; J K Crean; T J Sims; N Avery; S Smith; J Menage; S M Eisenstein; S Roberts Journal: Spine (Phila Pa 1976) Date: 1998-12-01 Impact factor: 3.468
Authors: S Capossela; P Schläfli; A Bertolo; T Janner; B M Stadler; T Pötzel; M Baur; J V Stoyanov Journal: Eur Cell Mater Date: 2014-04-04 Impact factor: 3.942